Dr. Roy C. Fox, MD
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Medical school
- University of Mississippi School of Medicine (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 630
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: University of Mississippi School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
TN license 16644 -
Pulmonary Disease Physician
TN license 16644
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Methodist Hospitals of Memphis Memphis, TN
- Baptist Memorial Hospital Memphis, TN
- Saint Francis Bartlett Medical Center Bartlett, TN
Medical groups
- Mid-South Pulmonary Specialists PC (47 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 630
- Services billed
- 2,656
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 732 | 324 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 482 | 174 |
| Test to measure expiratory airflow and volume | 360 | 243 |
| Established patient office or other outpatient visit, 20-29 minutes | 291 | 201 |
| Established patient office or other outpatient visit, 30-39 minutes | 183 | 116 |
| X-ray of chest, 1 view | 125 | 96 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 98 | 97 |
| X-ray of chest, 2 views | 76 | 74 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 55 | 55 |
| Ct scan of chest without contrast | 53 | 47 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Memphis, TN | 270 |
| Azithromycin Other prescribers in Memphis, TN | 140 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Memphis, TN | 118 |
| Prednisone Other prescribers in Memphis, TN | 97 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Memphis, TN | 81 |
| Montelukast Sodium Other prescribers in Memphis, TN | 57 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Memphis, TN | 35 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Memphis, TN | 33 |
| Budesonide-Formoterol Fumarate (budesonide/formoterol fumarate) Other prescribers in Memphis, TN | 21 |
| Methylprednisolone Other prescribers in Memphis, TN | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 101 payments worth $1,905 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $439 |
|---|---|
| GlaxoSmithKline, LLC. | $310 |
| Regeneron Healthcare Solutions, Inc. | $244 |
| Genzyme Corporation | $232 |
| Verona Pharma, Inc. | $100 |
| Amgen Inc. | $81.59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $80.41 |
| Genentech USA, Inc. | $79.46 |
| Food and Beverage | $1,905 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.